Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
- Status
- TERMINATED
- Phase
- PHASE4
Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)
- Status
- COMPLETED
- Phase
- N/A
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
- Status
- TERMINATED
- Phase
- PHASE2
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Vorapaxar and Lower Extremity Bypass Grafts
- Status
- WITHDRAWN
- Phase
- PHASE4
Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab in Refractory Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer
- Status
- COMPLETED
- Phase
- PHASE2